JASON KIMATA

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Molecular Virology & Microbiology
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    F32AI009337     (KIMATA, JASON T)Jan 31, 1997
    NIH
    CYTOPATHOGENIC DETERMINANTS OF SIV VARIANTS
    Role: Principal Investigator

    R56AI047725     (KIMATA, JASON T)Apr 15, 2000 - Mar 31, 2006
    NIH
    Replicative fitness of SIV variants
    Role: Principal Investigator

    R01AI047725     (KIMATA, JASON T)Apr 15, 2000 - Mar 31, 2012
    NIH
    Replicative fitness of SIV variants
    Role: Principal Investigator

    R21AI049803     (KIMATA, JASON T)Apr 15, 2001 - Mar 31, 2004
    NIH
    Strategies to Prevent SIV Binding to Macaque DC-SIGN
    Role: Principal Investigator

    R21AI083095     (KIMATA, JASON T)Apr 1, 2009 - Nov 30, 2012
    NIH
    Toward an HIV-1 macaque model
    Role: Principal Investigator

    R21AI099007     (KIMATA, JASON T)Feb 15, 2012 - Jan 31, 2015
    NIH
    HIV-1 Resistance to Type I Interferon in Macaques
    Role: Principal Investigator

    R01AI106574     (KIMATA, JASON T)Aug 15, 2013 - Jul 31, 2017
    NIH
    Inhibition of HIV by GPI-anchored Antibody Derivatives
    Role: Principal Investigator

    R56AI108467     (KIMATA, JASON T)Jul 2, 2014 - Jun 30, 2016
    NIH
    Replication and pathogenesis of pigtail-tropic HIV-1
    Role: Principal Investigator

    R21AI116167     (KIMATA, JASON T.)Aug 1, 2016 - Jul 31, 2018
    NIH
    Bifunctional Chimeric Antigen Receptors for clearing HIV
    Role: Principal Investigator

    R33AI116167     (KIMATA, JASON T.)Aug 1, 2016 - Jul 31, 2021
    NIH
    Bifunctional Chimeric Antigen Receptors for clearing HIV
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pollet J, Strych U, Chen WH, Versteeg L, Keegan B, Zhan B, Wei J, Liu Z, Lee J, Kundu R, Adhikari R, Poveda C, Villar MJ, Lopez B, Gillespie PM, Ronca S, Kimata JT, Reers M, Paradkar V, Hotez PJ, Bottazzi ME. Receptor-binding domain recombinant protein RBD219-N1C1 on alum-CpG induces broad protection against SARS-CoV-2 variants of concern. bioRxiv. 2021 Jul 07. PMID: 34268512.
      Citations: 1     
    2. Rice AP, Kimata JT. SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses. Future Virol. 2021 May. PMID: 34035830.
      Citations: 1     
    3. Pollet J, Chen WH, Versteeg L, Keegan B, Zhan B, Wei J, Liu Z, Lee J, Kundu R, Adhikari R, Poveda C, Villar MJ, de Araujo Leao AC, Altieri Rivera J, Momin Z, Gillespie PM, Kimata JT, Strych U, Hotez PJ, Bottazzi ME. SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. Hum Vaccin Immunother. 2021 08 03; 17(8):2356-2366. PMID: 33847226.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    4. Pollet J, Chen WH, Versteeg L, Keegan B, Zhan B, Wei J, Liu Z, Lee J, Kundu R, Adhikari R, Poveda C, Villar MJ, de Araujo Leao AC, Rivera JA, Momin Z, Gillespie PM, Kimata JT, Strych U, Hotez PJ, Bottazzi ME. SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice. bioRxiv. 2021 Feb 09. PMID: 33173864.
      Citations: 4     
    5. Spencer Clinton JL, Tran LL, Vogt MB, Rowley DR, Kimata JT, Rico-Hesse R. IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells. PLoS One. 2020; 15(12):e0244587. PMID: 33378361.
      Citations:    Fields:    Translation:HumansAnimalsCells
    6. Pons-Faudoa FP, Sizovs A, Shelton KA, Momin Z, Niles JA, Bushman LR, Xu J, Chua CYX, Nichols JE, Demaria S, Ittmann MM, Hawkins T, Rooney JF, Marzinke MA, Kimata JT, Anderson PL, Nehete PN, Arduino RC, Ferrari M, Sastry KJ, Grattoni A. Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates. Adv Ther (Weinh). 2021 Mar; 4(3). PMID: 33997267.
      Citations: 5     
    7. Li M, Liu W, Bauch T, Graviss EA, Arduino RC, Kimata JT, Chen M, Wang J. Author Correction: Clearance of HIV infection by selective elimination of host cells capable of producing HIV. Nat Commun. 2020 Dec 02; 11(1):6281. PMID: 33268775.
      Citations:    Fields:    
    8. Pons-Faudoa FP, Trani ND, Sizovs A, Shelton KA, Momin Z, Bushman LR, Xu J, Lewis DE, Demaria S, Hawkins T, Rooney JF, Marzinke MA, Kimata JT, Anderson PL, Nehete PN, Arduino RC, Sastry KJ, Grattoni A. Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant. Pharmaceutics. 2020 Oct 17; 12(10). PMID: 33080776.
      Citations: 3     
    9. Hosoki K, Kimata JT, Chakraborty A, Sur S. Reply. J Allergy Clin Immunol. 2020 12; 146(6):1455-1456. PMID: 33077246.
      Citations:    Fields:    Translation:Humans
    10. Li M, Liu W, Bauch T, Graviss EA, Arduino RC, Kimata JT, Chen M, Wang J. Clearance of HIV infection by selective elimination of host cells capable of producing HIV. Nat Commun. 2020 08 13; 11(1):4051. PMID: 32792548.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    11. Thippeshappa R, Kimata JT, Kaushal D. Toward a Macaque Model of HIV-1 Infection: Roadblocks, Progress, and Future Strategies. Front Microbiol. 2020; 11:882. PMID: 32477302.
      Citations: 2     
    12. Utay NS, Vigil KJ, Somasunderam A, Aulicino PC, Smulevitz B, Chiadika S, Wolf DS, Kimata JT, Arduino RC. Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations. AIDS Res Hum Retroviruses. 2020 04; 36(4):314-323. PMID: 31838858.
      Citations: 2     Fields:    Translation:HumansCells
    13. Liu H, Hu PW, Budhiraja S, Misra A, Couturier J, Lloyd RE, Lewis DE, Kimata JT, Rice AP. PACS1 is an HIV-1 cofactor that functions in Rev-mediated nuclear export of viral RNA. Virology. 2020 01 15; 540:88-96. PMID: 31759187.
      Citations: 2     Fields:    Translation:HumansCells
    14. Coggins SA, Holler JM, Kimata JT, Kim DH, Schinazi RF, Kim B. Efficient pre-catalytic conformational change of reverse transcriptases from SAMHD1 non-counteracting primate lentiviruses during dNTP incorporation. Virology. 2019 11; 537:36-44. PMID: 31442614.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    15. Zou J, Li W, Misra A, Yue F, Song K, Chen Q, Guo G, Yi J, Kimata JT, Liu L. Correction: The viral restriction factor Tetherin prevents leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) from association with Beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and enhances autophagy and mitophagy. J Biol Chem. 2019 Mar 29; 294(13):5211. PMID: 30926759.
      Citations:    Fields:    
    16. Misra A, Gleeson E, Wang W, Ye C, Zhou P, Kimata JT. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity. J Virol. 2018 04 01; 92(7). PMID: 29321330.
      Citations: 2     Fields:    Translation:HumansCells
    17. Auclair S, Liu F, Niu Q, Hou W, Churchyard G, Morgan C, Frahm N, Nitayaphan S, Pitisuthithum P, Rerks-Ngarm S, Kimata JT, Soong L, Franchini G, Robb M, Kim J, Michael N, Hu H. Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. PLoS Pathog. 2018 02; 14(2):e1006888. PMID: 29474461.
      Citations: 10     Fields:    Translation:HumansCells
    18. Spencer JL, Lahon A, Tran LL, Arya RP, Kneubehl AR, Vogt MB, Xavier D, Rowley DR, Kimata JT, Rico-Hesse RR. Replication of Zika Virus in Human Prostate Cells: A Potential Source of Sexually Transmitted Virus. J Infect Dis. 2018 01 30; 217(4):538-547. PMID: 28968863.
      Citations: 13     Fields:    Translation:HumansCells
    19. Wu B, Ouyang Z, Lyon CJ, Zhang W, Clift T, Bone CR, Li B, Zhao Z, Kimata JT, Yu XG, Hu Y. Plasma Levels of Complement Factor I and C4b Peptides Are Associated with HIV Suppression. ACS Infect Dis. 2017 12 08; 3(12):880-885. PMID: 28862830.
      Citations: 2     Fields:    Translation:Humans
    20. He H, Xue J, Wang W, Liu L, Ye C, Cong Z, Kimata JT, Qin C, Zhou P. Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector. Hum Gene Ther. 2017 03; 28(3):271-285. PMID: 28042947.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    21. Liu L, Wang W, Matz J, Ye C, Bracq L, Delon J, Kimata JT, Chen Z, Benichou S, Zhou P. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1. J Virol. 2016 Dec 01; 90(23):10642-10659. PMID: 27654286.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    22. Kimata JT, Rice AP, Wang J. Challenges and strategies for the eradication of the HIV reservoir. Curr Opin Immunol. 2016 10; 42:65-70. PMID: 27288651.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    23. Liu L, Wen M, Zhu Q, Kimata JT, Zhou P. Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor. J Neuroimmune Pharmacol. 2016 09; 11(3):601-10. PMID: 27155865.
      Citations: 7     Fields:    Translation:HumansCells
    24. Rice AP, Kimata JT. Subversion of Cell Cycle Regulatory Mechanisms by HIV. Cell Host Microbe. 2015 Jun 10; 17(6):736-40. PMID: 26067601.
      Citations: 8     Translation:HumansAnimalsCells
    25. Zou J, Li W, Misra A, Yue F, Song K, Chen Q, Guo G, Yi J, Kimata JT, Liu L. The viral restriction factor tetherin prevents leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) from association with beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and enhances autophagy and mitophagy. J Biol Chem. 2015 Mar 13; 290(11):7269-79. PMID: 25631043.
      Citations: 8     Fields:    Translation:HumansCells
    26. Wang W, Ye C, Liu J, Zhang D, Kimata JT, Zhou P. CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection. PLoS One. 2014; 9(12):e115987. PMID: 25541967.
      Citations: 77     Fields:    Translation:HumansCells
    27. Kimata JT. Stepping toward a macaque model of HIV-1 induced AIDS. Viruses. 2014 Sep 25; 6(9):3643-51. PMID: 25256394.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    28. Couturier J, Hutchison AT, Medina MA, Gingaras C, Urvil P, Yu X, Nguyen C, Mahale P, Lin L, Kozinetz CA, Schmitz JE, Kimata JT, Savidge TC, Lewis DE. HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies. Virology. 2014 Aug; 462-463:175-88. PMID: 24999042.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    29. Misra A, Thippeshappa R, Kimata JT. Macaques as model hosts for studies of HIV-1 infection. Front Microbiol. 2013; 4:176. PMID: 23825473.
      Citations: 12     
    30. Thippeshappa R, Ruan H, Wang W, Zhou P, Kimata JT. A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells. J Virol. 2013 Jun; 87(12):6678-92. PMID: 23552412.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    31. Liu L, Wang W, Yang L, Ren H, Kimata JT, Zhou P. Trimeric glycosylphosphatidylinositol-anchored HCDR3 of broadly neutralizing antibody PG16 is a potent HIV-1 entry inhibitor. J Virol. 2013 Feb; 87(3):1899-905. PMID: 23152526.
      Citations: 8     Fields:    Translation:Cells
    32. Thippeshappa R, Ruan H, Kimata JT. Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives. Biology (Basel). 2012 May 12; 1(2):134-64. PMID: 23336082.
      Citations: 9     
    33. Belshan M, Kimata JT, Brown C, Cheng X, McCulley A, Larsen A, Thippeshappa R, Hodara V, Giavedoni L, Hirsch V, Ratner L. Vpx is critical for SIVmne infection of pigtail macaques. Retrovirology. 2012 Apr 24; 9:32. PMID: 22531456.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    34. Gingaras C, Danielson BP, Vigil KJ, Vey E, Arduino RC, Kimata JT. Absence of XMRV in peripheral blood mononuclear cells of ARV-treatment naïve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors. PLoS One. 2012; 7(2):e31398. PMID: 22348082.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    35. Liu L, Wen M, Wang W, Wang S, Yang L, Liu Y, Qian M, Zhang L, Shao Y, Kimata JT, Zhou P. Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16. J Virol. 2011 Sep; 85(17):8467-76. PMID: 21715497.
      Citations: 10     Fields:    Translation:HumansCells
    36. Thippeshappa R, Polacino P, Yu Kimata MT, Siwak EB, Anderson D, Wang W, Sherwood L, Arora R, Wen M, Zhou P, Hu SL, Kimata JT. Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1. J Virol. 2011 Apr; 85(8):3767-79. PMID: 21289128.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    37. Biesinger T, White R, Yu Kimata MT, Wilson BK, Allan JS, Kimata JT. Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation. Retrovirology. 2010 Oct 13; 7:88. PMID: 20942954.
      Citations: 7     Fields:    Translation:AnimalsCells
    38. Danielson BP, Ayala GE, Kimata JT. Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J Infect Dis. 2010 Nov 15; 202(10):1470-7. PMID: 20936978.
      Citations: 42     Fields:    Translation:HumansCells
    39. Wen M, Arora R, Wang H, Liu L, Kimata JT, Zhou P. GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike. Retrovirology. 2010 Oct 06; 7:79. PMID: 20923574.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    40. Arora R, Bull L, Siwak EB, Thippeshappa R, Arduino RC, Kimata JT. Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levels. J Acquir Immune Defic Syndr. 2010 Jun; 54(2):115-21. PMID: 20386455.
      Citations: 3     Fields:    Translation:HumansCells
    41. Graham SM, Holte S, Kimata JT, Wener MH, Overbaugh J. A decrease in albumin in early SIV infection is related to viral pathogenicity. AIDS Res Hum Retroviruses. 2009 Apr; 25(4):433-40. PMID: 19320603.
      Citations: 2     Fields:    Translation:AnimalsCells
    42. Eastman D, Piantadosi A, Wu X, Forthal DN, Landucci G, Kimata JT, Overbaugh J. Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses. Virol J. 2008 Aug 04; 5:90. PMID: 18680596.
      Citations: 4     Fields:    Translation:AnimalsCells
    43. Biesinger T, Kimata JT. HIV-1 Transmission, Replication Fitness and Disease Progression. Virology (Auckl). 2008 Jul 14; 2008(1):49-63. PMID: 20354593.
      Citations: 4     
    44. Biesinger T, Yu Kimata MT, Kimata JT. Changes in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4+ T cells. Virology. 2008 Jan 05; 370(1):184-93. PMID: 17904609.
      Citations: 6     Fields:    Translation:AnimalsCells
    45. Ambrose Z, Palmer S, Boltz VF, Kearney M, Larsen K, Polacino P, Flanary L, Oswald K, Piatak M, Smedley J, Shao W, Bischofberger N, Maldarelli F, Kimata JT, Mellors JW, Hu SL, Coffin JM, Lifson JD, KewalRamani VN. Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. J Virol. 2007 Nov; 81(22):12145-55. PMID: 17855539.
      Citations: 36     Fields:    Translation:HumansAnimalsCells
    46. Polacino P, Cleveland B, Zhu Y, Kimata JT, Overbaugh J, Anderson D, Hu SL. Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge. J Med Primatol. 2007 Aug; 36(4-5):254-65. PMID: 17669214.
      Citations: 19     Fields:    Translation:AnimalsCells
    47. Biggins JE, Biesinger T, Yu Kimata MT, Arora R, Kimata JT. ICAM-3 influences human immunodeficiency virus type 1 replication in CD4(+) T cells independent of DC-SIGN-mediated transmission. Virology. 2007 Aug 01; 364(2):383-94. PMID: 17434553.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    48. Lee SJ, Arora R, Bull LM, Arduino RC, Garza L, Allan J, Kimata JT, Zhou P. A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGN. AIDS Res Hum Retroviruses. 2006 Sep; 22(9):874-83. PMID: 16989613.
      Citations: 3     Fields:    Translation:HumansCells
    49. Liu H, Dow EC, Arora R, Kimata JT, Bull LM, Arduino RC, Rice AP. Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes. J Virol. 2006 Aug; 80(15):7765-8. PMID: 16840357.
      Citations: 15     Fields:    Translation:HumansCells
    50. Kimata JT. HIV-1 fitness and disease progression: insights from the SIV-macaque model. Curr HIV Res. 2006 Jan; 4(1):65-77. PMID: 16454712.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    51. AP Rice JT Kimata. Cellular co-factors and HIV-1 infection in vivo. Future Virology. 2006; 1(3):337-347. View Publication.
    52. Kimata JT, Wilson JM, Patel PG. The increased replicative capacity of a late-stage simian immunodeficiency virus mne variant is evident in macrophage- or dendritic cell-T-cell cocultures. Virology. 2004 Oct 01; 327(2):307-17. PMID: 15351218.
      Citations: 8     Fields:    Translation:AnimalsCells
    53. Biggins JE, Yu Kimata MT, Kimata JT. Domains of macaque DC-SIGN essential for capture and transfer of simian immunodeficiency virus. Virology. 2004 Jun 20; 324(1):194-203. PMID: 15183066.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    54. Yu Kimata MT, Cella M, Biggins JE, Rorex C, White R, Hicks S, Wilson JM, Patel PG, Allan JS, Colonna M, Kimata JT. Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN. J Virol. 2002 Dec; 76(23):11827-36. PMID: 12414925.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    55. Patel PG, Yu Kimata MT, Biggins JE, Wilson JM, Kimata JT. Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens. J Virol. 2002 Jul; 76(13):6425-34. PMID: 12050354.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    56. Baribaud F, Pöhlmann S, Sparwasser T, Kimata MT, Choi YK, Haggarty BS, Ahmad N, Macfarlan T, Edwards TG, Leslie GJ, Arnason J, Reinhart TA, Kimata JT, Littman DR, Hoxie JA, Doms RW. Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN. J Virol. 2001 Nov; 75(21):10281-9. PMID: 11581396.
      Citations: 27     Fields:    Translation:HumansAnimalsCells
    57. Diamond TL, Kimata J, Kim B. Identification of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection. J Biol Chem. 2001 Jun 29; 276(26):23624-31. PMID: 11325971.
      Citations: 10     Fields:    Translation:AnimalsCells
    58. Kimata JT, Kuller L, Anderson DB, Dailey P, Overbaugh J. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat Med. 1999 May; 5(5):535-41. PMID: 10229230.
      Citations: 79     Fields:    Translation:AnimalsCells
    59. Kimata JT, Gosink JJ, KewalRamani VN, Rudensey LM, Littman DR, Overbaugh J. Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne. J Virol. 1999 Feb; 73(2):1655-60. PMID: 9882375.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    60. Kimata JT, Mozaffarian A, Overbaugh J. A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells. J Virol. 1998 Jan; 72(1):245-56. PMID: 9420221.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    61. Rudensey LM, Kimata JT, Long EM, Chackerian B, Overbaugh J. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J Virol. 1998 Jan; 72(1):209-17. PMID: 9420217.
      Citations: 56     Fields:    Translation:HumansAnimalsCells
    62. Kimata JT, Overbaugh J. The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env. J Virol. 1997 Oct; 71(10):7629-39. PMID: 9311845.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    63. Rudensey LM, Kimata JT, Benveniste RE, Overbaugh J. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology. 1995 Mar 10; 207(2):528-42. PMID: 7886956.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    64. Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A. 1995 Feb 14; 92(4):1057-61. PMID: 7862633.
      Citations: 144     Fields:    Translation:HumansAnimalsCells
    65. Kimata JT, Wong FH, Wang JJ, Ratner L. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology. 1994 Nov 01; 204(2):656-64. PMID: 7941334.
      Citations: 82     Fields:    Translation:HumansCells
    66. Kimata JT, Wong FH, Ratner L. CD3-dependent lymphocyte activation by human T cell leukaemia virus type I-producing T cells. J Gen Virol. 1994 Sep; 75 ( Pt 9):2433-7. PMID: 7915756.
      Citations: 1     Fields:    Translation:HumansCells
    67. Kimata JT, Palker TJ, Ratner L. The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway. J Virol. 1993 Jun; 67(6):3134-41. PMID: 7684460.
      Citations: 14     Fields:    Translation:HumansCells
    68. Kimata JT, Ratner L. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J Virol. 1991 Aug; 65(8):4398-407. PMID: 2072456.
      Citations: 16     Fields:    Translation:HumansCells
    69. Bryant ML, Heuckeroth RO, Kimata JT, Ratner L, Gordon JI. Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc Natl Acad Sci U S A. 1989 Nov; 86(22):8655-9. PMID: 2813417.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    70. Kimata JT, Kaneshiro SA, Kwock DW, Nakamura S, Kaneshiro MM, Nakamura JM. A seroepidemiologic survey of human T-cell lymphotropic virus type I in two Hawaiian hematologic-oncologic practices. West J Med. 1989 Mar; 150(3):300-2. PMID: 2735036.
      Citations: 2     Fields:    Translation:Humans
    71. Nakamura J, Kawahara K, Kwock D, Kimata J, Kaneshiro S, Nakamura S, Yanagihara E. HTLV-1 seroconversion in a 56-year-old Japanese woman undergoing chemotherapy for acute nonlymphocytic leukemia. Hawaii Med J. 1988 Jun; 47(6):269-70, 273. PMID: 2900228.
      Citations: 1     Fields:    Translation:Humans
    KIMATA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (302)
    Explore
    _
    Co-Authors (23)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _